Background illustration for clinical trials search

Paid Clinical Trials Edmonton

Discover 447 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Trial of exSALT SD7™ Compared to Xeroform® Petrolatum Dressing for the Management of Partial Thickness Donor Sites

for
Wound Healing, Wound Infection
Location: Edmonton
Sponsor: Exciton Technologies Inc.

Sex: All

Age: 18 - 65

Code: NCT00968994

Recruiting

First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)

for
Amyotrophic Lateral Sclerosis (ALS),
Location: Edmonton, London, Toronto, Montreal
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06351592

Phase1, Phase2, Recruiting

A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

for
Chronic Kidney Disease
Location: Edmonton, Saskatoon, Vancouver, Seattle WA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 2 - 17

Code: NCT07107945

Phase3, Recruiting

Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients

for
Respiratory Failure
Location: Edmonton, St. Albert
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT07359261

Phase2, Recruiting

Augmented Renal Clearance in Neurocritical Care

for
TBI (Traumatic Brain Injury), Status Epilepticus,
Location: Edmonton, Columbus OH, Lexington KY
Sponsor: University of Alberta

Sex: All

Age: 18 - 70+

Code: NCT07410624

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

for
Microvascular Inflammation
Location: Edmonton, Seattle WA, Rochester MN, San Francisco CA,
Sponsor: Biogen

Sex: All

Age: 18 - 70+

Code: NCT07219043

Phase2, Recruiting

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

for
Intracerebral Hemorrhage
Location: Edmonton, Calgary, Vancouver, Portland OR, Winnipeg,
Sponsor: Joseph Broderick, MD

Sex: All

Age: 18 - 70+

Code: NCT07227246

Phase3, Recruiting

Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent

for
Fecal Incontinence, Urinary Incontinence, Diaper Rash,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT07524439

Recruiting

Ketorolac at Lower Doses for Analgesic Pain Control in ICU: A Pilot Feasibility Study

for
Pain Management
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06819956

Phase3, Recruiting

Feasibility and Pilot Testing of "My Heart and CKD" Online Shared Decision Aid

for
Chronic Kidney Disease, Coronary Artery Disease
Location: Edmonton, Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT06920927

Recruiting

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

for
Malignant Glioma
Location: Edmonton, Saskatoon, Spokane WA, Seattle WA, Tacoma WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 21

Code: NCT05099003

Phase1, Phase2, Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

for
Multiple Sclerosis Spasticity
Location: Edmonton, Kirkland WA, Kansas City KS, Scottsdale AZ,
Sponsor: Celgene

Sex: All

Age: 18 - 70

Code: NCT06782490

Phase2, Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Edmonton, Spokane WA, Seattle WA, Tacoma WA, Boise ID,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Edmonton, Spokane WA, Vancouver, Seattle WA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

Personalized Anti-Inflammatory Fibres in Ulcerative Colitis

for
Ulcerative Colitis
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 14+

Code: NCT06515210

Recruiting

Nimodipine Variability in SAH

for
Subarachnoid Aneurysm Hemorrhage,
Location: Edmonton, Toronto, Richmond VA
Sponsor: University of Alberta

Sex: All

Age: 18 - 70+

Code: NCT07065903

Recruiting

Platform of Randomized Adaptive Clinical Trials in Critical Illness

for
Respiratory Insufficiency,
Location: Edmonton, Calgary, Saskatoon, Surrey, Vancouver,
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05440851

Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Edmonton, Calgary, Seattle WA, Tacoma WA, Fargo ND,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase2, Recruiting

Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

for
Acute Ischemic Stroke
Location: Edmonton, Calgary, Vancouver, Torrance CA,
Sponsor: Basking Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06226805

Phase2, Recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

for
End Stage Kidney Disease
Location: Edmonton, Vancouver, Winnipeg, Reno NV, Arvada CO,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT05485961

Phase2, Phase3, Recruiting